Evidence map›Paper›PMID 33837890›Full record

Trial reportPrevention science : the official journal of the Society for Prevention Research2021

Long-term Impacts and Benefit-Cost Analysis of the Communities That Care Prevention System at Age 23, 12 Years After Baseline.

Margaret R Kuklinski, Sabrina Oesterle, John S Briney, J David Hawkins

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Prevention science : the official journal of the Society for Prevention Research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
9.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 43 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Annual Research Review: Beyond the target - understanding crossover effects in family-centered prevention.Journal of child psychology and psychiatry, and allied disciplines · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Substance Use Disorders: Population Prevention.Focus (American Psychiatric Publishing) · 2024
    Article
  13. Article
  14. Family-Focused Universal Substance Use Prevention in Primary Care: Advancing a Pragmatic National Healthcare Agenda.Prevention science : the official journal of the Society for Prevention Research · 2024
    Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Margaret R KuklinskiSocial Development Research Group, School of Social Work, University of Washington, 9725 Third Avenue NE, Suite 401, Seattle, WA, 98115 , USA. mrk63@uw.edu.ORCID 0000-0002-3475-4471
Sabrina OesterleSouthwest Interdisciplinary Research Center, School of Social Work, Arizona State University, 201 N Central Ave, 33rd floor, Phoenix, AZ, 85004, USA.
John S BrineySocial Development Research Group, School of Social Work, University of Washington, 9725 Third Avenue NE, Suite 401, Seattle, WA, 98115 , USA.
J David HawkinsSocial Development Research Group, School of Social Work, University of Washington, 9725 Third Avenue NE, Suite 401, Seattle, WA, 98115 , USA.
University of Washington · USArizona State University · US

Funding

The Community Youth Development Study: A Test of Communities That CareR01DA015183 · NIDA · UNIVERSITY OF WASHINGTON · PI HAWKINS, J DAVID, OESTERLE, SABRINA · 2003 to 2016
$34.0M
NIDA NIH HHS R01 DA015183NIDA NIH HHS R01 DA015183-15A1
6 · The paper itself

Abstract

This study estimated sustained impacts and long-term benefits and costs of the Communities That Care (CTC) prevention system, implemented and evaluated in a longitudinal cluster-randomized trial involving 24 communities in seven states. Analyses utilized reports from a longitudinal panel of 4407 participants, followed since the study's baseline in grade 5, with most recent follow-up 12 years later at age 23. Impacts on lifetime abstinence from primary outcomes of substance use and antisocial behavior were estimated using generalized linear mixed Poisson regression analysis, adjusted for individual and community-level covariates. Possible cascading effects on 4-year college completion, major depressive disorder, and generalized anxiety disorder through age 23 were evaluated as secondary outcomes. CTC had a statistically significant global effect on primary outcomes and also on combined primary and secondary outcomes. Among primary outcomes, point estimates suggested absolute improvements in lifetime abstinence of 3.5 to 6.1% in the intervention arm and relative improvements of 13 to 55%; 95% confidence intervals revealed some uncertainty in estimates. Among secondary outcomes, 4-year college completion was 1.9% greater among young adults from intervention communities, a 20% relative improvement. Mental health outcomes were approximately the same across trial arms. Although CTC had small sustained effects through age 23, benefit-cost analyses indicated CTC was reliably cost beneficial, with a net present value of $7152 (95% credible interval: $1253 to $15,268) per participant from primary impacts and $17,919 ($306 to $39,186) when secondary impacts were also included. It remained cost beneficial even when impacts were adjusted downward due to the involvement of CTC's developer in the trial. Findings suggest that broader dissemination of CTC could improve public health and individual lives in the long term and generate positive net benefits to society.

Indexed as

Anxiety DisordersEducational StatusMajor Depressive DisorderPrimary PreventionSubstance-Related DisordersChildCost-Benefit AnalysisHumansLongitudinal StudiesUnited StatesYoung AdultBenefit–cost analysisCommunities That CareLong-term impacts

Identifiers

PMID33837890
PMCPMC8375313
OpenAlexW3143978956

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.